Editorial: Molecular imaging in drug development

Current Pharmaceutical Design

Volumn 13, Issue 1, 2007, Pages 1-

  Kassiou, Michael ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER 64; INTEGRIN; LIGAND; MATRIX METALLOPROTEINASE; NEUROLEPTIC AGENT; NEUROPROTECTIVE AGENT; NOOTROPIC AGENT; OPIATE; SIGMA OPIATE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; DIAGNOSTIC IMAGING; DRUG DESIGN; DRUG RESEARCH; DRUG SYNTHESIS; EDITORIAL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; ISOTOPE LABELING; ISOTOPE TRACING; MOLECULAR IMAGING; MOLECULAR INTERACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN TARGETING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TARGET CELL;

EID: 33846150633     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207779313803     Document Type: Editorial

References (4)

1. Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Copper Chelation Chemistry and Its Role in Copper Radiopharmaceuticals. Curr Pham Des 2007; 13(1): 3-16.
2. Choe YS, Lee K.-H. Targeted In Vivo Imaging of Angiogenesis: Present Status and Perspectives. Curr Pham Des 2007; 13(1): 17-31.
3. Lever JR. PET and SPECT Imaging of the Opioid System: Receptors, Radioligands and Avenues for Drug Discovery and Development. Curr Pham Des 2007; 13(1): 33-49.
4. Collier TL, Waterhouse RN, Kassiou M. Imaging Sigma Receptors: Applications in Drug Development. Curr Pham Des 2007; 13(2): 51-72.